Wednesday 15th November

Room 1 Room 2 Room 3
09.00-10.30 E1W
CNC of Drug Utilization
E2W
Time Series Analysis
E3W
Data Sources – Validation Research
10.30-11.00 Coffee Break
11.00-12.30 E4W
Adherence Research Using Databases
E5W
Quality of Quality Indicators
E6W
Using Field Studies in DUR
12.30-13.30 Lunch Break
Scientific Programme Part I
13.30-15.00 Welcome
Keynote Lectures
K1W
Digital Health: The Future is Here
Thomas Balkizas
K2W
Digitalizing and DUR: Challenges and Oppurtunities
Björn Wettermark
15.00 -16.00 Coffee Break
16.00 -17.30 P1W
Antimicrobial Use and Resistance
P2W
ePrescribing and eDispensing Systems
P3W
Adherence

Thursday 16th November

Room 1 Room 2 Room 3
Scientific Programme Part II
08.30-10.00 P4T
Prescribing and de-Prescribing in Old Age
P5T
Gender Difference and Safety in DU
P6T
Decision Support to Improve Drug Use
10.00-10.30 Coffee Break
10.30-12.00 P7T
Globalization of DUR
P8T
Drug Use in Pregnancy and Pediatrics
P9T
Evolving Methods in DUR
12.00-13.00 Lunch Break
Scientific Programme Part III
13.00-14.30 W1T
DUR on the Life Cycle of Drugs
S2T
Data Visualization
W3T
From Intervention to Implementation
How Can Science Help?
14.30-16.00 Coffee Break & Poster Walk
16.00-17.30 Keynote Lectures
K3T
Health Informatics – Taking a “Molecule to Man “ Approach
Andrew Morris
K4T
Patient Perspective – The Patient and Public Voice – Using Big Data for Public Benefit
Sarah Cunningham Burley

Friday 17th November

Room 1 Room 2 Room 3
Scientific Programme Part IV
08.30-10.00 P10F
Inform and Evaluate Health Policy
P11F
Citizen Science and DUR
P12F
Cardiovascular Therapy
10.00-10.30 Coffee Break
10.30-12.00 P13F
Patient Reported Outcome Measures
P14F
New Medicines: Management of Innovations
P15F
DUR Across the World
12.00-13.00 Lunch Break
Scientific Programme Part V
13.00-14.30 S4F
Predictive Analytics, Patient Level Drug Exposure
W5F
Role of DUR in Comparative Effectiveness Research
W6F
CNC Guidelines and Checklist
14.30-16.00 Coffee Break & Poster Walk
16.00-17.30 Closing Ceremony
Keynote Lecture
K5F
Drug Utilization and Health Policy from a Global Perspective